Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Gaylord Palms Resort & Convention Center

Mar 21, 2016 1:00 PM - Mar 23, 2016 4:30 PM

6000 West Osceola Parkway, Kissimmee, FL 34746

Medical Affairs and Scientific Communications 2016 Annual Forum

Cross-functional forum spotlights topics related to medical communication, medical science liaison, medical call center, and medical writing professionals.

Session 3 Track D: The Broad Global Impact of EMA’s Transparency Policy

Session Chair(s)

Robert  Paarlberg, MS

Robert Paarlberg, MS

Principal

Paarlberg & Associates LLC, United States

The European Medicines Agency's (EMA) Publication Policy 0070 enables public access to clinical overviews, clinical summaries and clinical study reports included in a Marketing Authorization (MA) or Postmarketing Authorization. Clinical data that were submitted under the centralized procedure after January 1, 2015, (including clinical trials conducted outside the EU or EEA that were included in the MA) will be posted on the EMA website. Under Policy 0070, companies must balance public health interests while ensuring the privacy of patients identified in regulatory submissions.

This session will provide an early assessment of Policy 0070, highlight some potential challenges encountered in the de-identification of patient data, and discuss the challenges in writing a clinical study report with disclosure in mind.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Discuss the current status of EMA Publication Policy 0070
  • Recognize the potential risks of jeopardizing personal privacy by disclosing specific clinical trial patient data
  • Discuss how clinical study reports can be written with disclosure in mind
  • Describe the challenges of redacting commercially confidential information and anonymization of personal data in clinical study reports

Speaker(s)

Robert  Paarlberg, MS

EMA’s Clinical Data Transparency Policy – Where Are We?

Robert Paarlberg, MS

Paarlberg & Associates LLC, United States

Principal

Helle  Gawrylewski, MA

Options for Data Sharing: Industry Implementation

Helle Gawrylewski, MA

Hawkwood Consulting, LLC, United States

Owner

Ann  Winter-Vann, PhD

Best Practices for Writing Clinical Study Reports for Disclosure

Ann Winter-Vann, PhD

Whitsell Innovations, Inc., United States

Senior Writer and Manager

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.